ADDENDUM TO RFA-RM-04-018,  NANOMEDICINE CENTER CONCEPT DEVELOPMENT AWARDS 

RELEASE DATE:  July 1, 2004

NOTICE:  NOT-RM-04-013

National Institutes of Health (NIH)
 (http://www.nih.gov)

This notice is an addendum to RFA-RM-04-018,  Nanomedicine Center Concept Development 
Awards  at (http://grants.nih.gov/grants/guide/rfa-files/RFA-RM-04-018.html)
which was released in the NIH Guide for Grants and Contracts on May 4, 2004.  It 
clarifies various issues and requirements related to the Concept Development 
Memo (CDM), Concept Development Award (CDA), and Concept Development Plan (CDP) 
described in this RFA.

o  Letters of collaboration from any investigators who are not employed by the 
applicant organization should be included with the CDM.

o  Applicants need not submit the percent level of effort for key personnel.

o  Information on Other Support should not be included in the CDM.

o  An institution may submit more than one CDM.

o  Investigators may be included as key personnel on more than one CDM.

o  A management plan should be included if multiple institutions are involved.

o  Individuals who have applied or intend to apply to other RFAs specifically 
targeted to nanotechnology or nanomedicine are still eligible to submit a CDM.

o  CDAs will be issued for a period of six months, i.e., until March 31, 2005.  
Funds may be used for planning activities and may include travel for key 
personnel to the March, 2005 meeting.  No supplements to CDAs will be issued for 
additional planning or for writing the Centers application.  However, if CDA 
funds remain at the end of the budget period, a four month no-cost extension may 
be requested.

o  If a large number of CDMs is received, a triage process will be used to 
select the most meritorious CDMs for full review.

o  Applicants will receive two emails.  The first will indicate receipt of the 
CDM and will be sent within two weeks of receipt.  The second will provide a 
brief summary of the review and its outcome.  If a CDM is triaged, the second 
email will not include a review summary.

o  The abstract of CDAs will be published on the NIH Nanomedicine Roadmap 
website.  The purpose of this posting is to facilitate development of additional 
collaborations.  Investigators interested in collaborating with awardees will be 
encouraged to contact the awardees.

o  Each group that receives a CDA may submit a CDP and, in turn, may submit a 
centers application in July, 2005.  CDA applicants who are unsuccessful this 
fiscal year may not apply for a Nanomedicine Development Center grant in fiscal 
year 2005.  If another round of centers will be funded in FY 2006 as expected, 
previously unsuccessful applicants would be eligible to reapply.

o  The Nanomedicine Roadmap plans include funding for additional Centers in 
fiscal years 2006 ($6M) and 2008 ($13M).  Such funds may also be used for 
expanding the scope of one or more of the Centers funded in 2005, or for 
supporting interactions within the network of Centers.  The CDM may address use 
of future funding increments.

INQUIRIES:

Richard S. Fisher, Ph.D.
Project Team Leader, Nanomedicine Roadmap Initiative
Division of Extramural Research
National Eye Institute
5635 Fishers Lane, Room 1300
Bethesda, MD  20892-9300
Telephone:  (301) 451-2020
Email:   [email protected]

Support for the NIH Roadmap and its initiatives is provided by all Institutes 
and Centers, whose representatives direct and oversee each initiative.  The 
National Eye Institute (NEI) is the lead administrative institute for the 
Nanomedicine Initiative.

Weekly TOC for this Announcement
NIH Funding Opportunities and Notices

			Department of Health and Human Services (HHS)
NIH... Turning Discovery Into Health®